Oasmia Pharmaceutical and Xenetic Biosciences among healthcare gainers; Intra-Cellular Therapies leads the losers

• Gainers: Soliton (NASDAQ:SOLY) +26%. Oasmia Pharmaceutical (NASDAQ:OASM) +24%. Xenetic Biosciences (NASDAQ:XBIO) +13%. Sol-Gel Technologies (NASDAQ:SLGL) +13%. Soleno Therapeutics (NASDAQ:SLNO) +13%.
• Losers: Intra-Cellular Therapies (NASDAQ:ITCI) -24%. CannTrust Holdings (NYSE:CTST) -19%. Coherus BioSciences (NASDAQ:CHRS) -16%. Jaguar Health (NASDAQ:JAGX) -12%. Melinta Therapeutics (NASDAQ:MLNT) -12%.